Anavex is late like the sun comes up and still produces great results.

Remi (mostly his handlers, praise be) will take all the time they need to package it correctly and produce it in a way that even Madam Fürherstain won’t be able to besmirch,

Blarcamesine is More effective, safer, cheaper to produce, and easier to administer than any late stage big pharma Alzheimer treatment EVER.

With SMFL greens line, manufacturing facility, and USA presence makes perfect sense.

$BLUE since just starting ramping of 2 approved treatments, eps s/b pretty easy (mostly expenses).

I’m hopeful it’s because they’re extremely confident in love-cel and ramping up the budget for launch next year 🚀

$BLUE agreed, even without a b/o, too much bullish fundamental news and any announcement on further progress on pipeline or ramping up the current 2 approvals should provide fuel for that push through double digits